New pet scan to detect annexin a2 in lung tumors
Part of Cancer clinical trials.
This trial tests a new injection called 68Ga-PFA2 for PET/CT scans to find a protein called Annexin A2 in lung cancer tumors. It aims to see if this scan can better detect or characterize these tumors in patients who will have a biopsy or surgery soon.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with lung cancer.
- You are scheduled for a biopsy or surgery within the next two months.
- You are able to understand the study and give your consent.
- You can cooperate with the scan procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests a special whole-body scan (PET/CT) that uses injected tracers to help show where lung cancer may be. It may help researchers see tumors more clearly and compare different tracers during the same time window.
This trial tests a new imaging agent called 68Ga-DPA to see if it can help find and measure lung cancer tumors. It is for people who are suspected or confirmed to have lung cancer and need a biopsy or surgery soon.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This trial tests a new type of imaging scan that uses a special tracer to help doctors see solid tumors more clearly. The scan may help improve how tumors are detected and monitored during treatment.
This Phase 2 study tests whether a new imaging medicine (a radiopharmaceutical) can highlight immune cells called macrophages in people with non-small cell lung cancer. It may help doctors better “see” and evaluate tumor tissue before a surgical biopsy or removal.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
Hear when a new Breast Neoplasms、Lung Neoplasms、Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.